KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medtronic (MDT) EBT (2016 - 2025)

Historic EBT for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $1.6 billion.

  • Medtronic's EBT rose 243.75% to $1.6 billion in Q4 2025 from the same period last year, while for Oct 2025 it was $5.7 billion, marking a year-over-year increase of 1059.37%. This contributed to the annual value of $5.6 billion for FY2025, which is 1635.31% up from last year.
  • Per Medtronic's latest filing, its EBT stood at $1.6 billion for Q4 2025, which was up 243.75% from $1.3 billion recorded in Q3 2025.
  • In the past 5 years, Medtronic's EBT registered a high of $1.6 billion during Q2 2022, and its lowest value of $833.0 million during Q3 2021.
  • Moreover, its 5-year median value for EBT was $1.4 billion (2022), whereas its average is $1.4 billion.
  • Per our database at Business Quant, Medtronic's EBT soared by 66390.24% in 2021 and then crashed by 4487.43% in 2024.
  • Over the past 5 years, Medtronic's EBT (Quarter) stood at $1.5 billion in 2021, then decreased by 6.56% to $1.4 billion in 2022, then dropped by 5.88% to $1.3 billion in 2023, then grew by 18.74% to $1.6 billion in 2024, then rose by 2.44% to $1.6 billion in 2025.
  • Its EBT stands at $1.6 billion for Q4 2025, versus $1.3 billion for Q3 2025 and $1.3 billion for Q2 2025.